Below is a list of bills among those that CSAP has taken positions on that will be heard in their First House policy committees in the next month.

SB 987 (Weber Pierson) – SB 987 would establish the California Health Access Fund to ensure that state savings resulting from Medi-Cal coverage losses under H.R. 1 are reinvested to maintain access to care and reimburse providers for services delivered to individuals who lose coverage. – Support

SB 1221 (Stern) – SB 1221 would prioritize placement of dangerous, incompetent defendants who have been conserved on Public Safety Conservatorships (Murphy Conservatorships). It would ensure that the party most closely associated with the victim and public safety interests, the District Attorney, has full access to the conservatorship hearings. It would also update evaluation standards of the Public Conservator/Guardian when evaluating potential conservatees to be consistent with SB 820 (Stern, 2025). – Support

SB 1242 (Choi) – SB 1242 would allow a family member as the original petitioner to participate throughout CARE Court proceedings for care coordination, unless the CARE Court determines that such participation would be detrimental to the respondent’s treatment or well-being. – Support

AB 2275 (Bains) – AB 2275 would amend California’s mental health pretrial diversion program by adding stricter eligibility requirements – including a recent written diagnosis and a finding of mental competency – while also expanding the list of disqualifying offenses. Additionally, it also removes the court’s authority to grant diversion to defendants who have been found mentally incompetent. – Oppose

AB 2489 (Lowenthal) – AB 2489 would authorize the Research Advisory Panel of California (RAP-C) to approve clinical trials involving controlled substances, including psilocybin, through an expedited process that can occur independent of the federal Food and Drug Administration (FDA) approval. – Oppose

AB 2249 (Irwin) – AB 2249 would prohibit the sale and manufacturing of cannabis products that are attractive to children through the creation of a process for the Department of Cannabis Control (DCC) to advise licensees of when their cannabis packaging and labeling is attractive. – Support

You may view a full list of CSAP’s bill positions here.